REG - Frontier IP Group - Total Voting Rights
RNS Number : 5863RFrontier IP Group plc30 June 202030 June 2020
Frontier IP Group plc
("Frontier IP" or the "Company")
Total Voting Rights
Frontier IP (AIM: FIPP), a specialist in commercialising intellectual property, announces that the Company's issued share capital as at the date of this announcement comprises 50,762,406 ordinary shares of 10 pence each ("Ordinary Shares"), with one voting right per share. The Company does not hold any ordinary shares in treasury and therefore the total number of Ordinary Shares with voting rights in the Company is 50,762,406.
The above figure of 50,762,406 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries
Frontier IP Group plc
T: 0131 240 1251
Neil Crabb, Chief Executive Officer
Andrew Johnson, Communications & Investor Relations
M: 07464 546 025
Allenby Capital Limited (Nominated Adviser)
T: 0203 328 5656
Nick Athanas / Nicholas Chambers
N+1 Singer (Broker)
T: 0207 496 3000
Harry Gooden / George Tzimas
ABOUT FRONTIER IP: www.frontierip.co.uk
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.
The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDTVRBSGDLLUXDGGG
Recent news on Frontier IP
See all newsRCS - Frontier IP Group - TVG's vaccine candidate enters animal trials
AnnouncementRCS - Frontier IP Group - Syva signs option to license agreement with TVG
AnnouncementREG - Frontier IP Group - Director/PDMR Shareholding
AnnouncementREG - Frontier IP Group - Director/PDMR Shareholding
AnnouncementREG - Frontier IP Group - Unaudited Half Year Results
Announcement